Neuropeptide Y and Derivates Are Not Ready for Prime Time in Prostate Cancer Early Detection

Neuropeptide Y (NPY) and related peptides have been proposed as promising biomarkers for the diagnosis of prostate cancer by previous immunoassays and immunohistochemical studies. In this study, we evaluated the additional value of NPY and related peptides compared with prostate-specific antigen (PS...

Descripció completa

Dades bibliogràfiques

Autors principals:	Jonathan Maurer, Philippe J. Eugster, Kiana Collins, Céline Vocat, Jason Oke, Brian Nicholson, Arnas Rakauskas, Eric Grouzmann, Massimo Valerio
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2024-08-01
Col·lecció:	European Urology Open Science
Matèries:	Biomarker Diagnosis Neuropeptide Y Pro-neuropeptide Y Prostate cancer Prostate-specific antigen
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2666168324004646
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!